| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 |
| filingDate |
2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de4539faec0dda442bf80e5a5d47a070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c469a7c122fbc26584438c991f30bd79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80bb7fa87737725f93000fad9d9d4f68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55ff49eec8becdccae0befa172b9eee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1af12d37c2a54849b04ff830e18fc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15012a8267b5e644c443652546c07297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673e40e3bdaffe978f2127a3201012c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d34c9f139a954291c28efd2981b1846d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b460a5589d52d382bd1bcc7da2cc3b1 |
| publicationDate |
2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7396931-B2 |
| titleOfInvention |
Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| abstract |
The present invention relates to a new method of preparation of the polymorph form 1 of methyl (S)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate of the formula (I) |
| priorityDate |
2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |